Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Use of Extracorporeal Photopheresis (ECP) After Lung Transplantation

NCT05721079 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05721079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Use of Extracorporeal Photopheresis (ECP) After Lung Transplantation
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
December 31, 2022
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant infection, lung transplant rejection